Inspire Medical Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	135.04	145.42	53.51	-21.15	-44.88	-42.04
Depreciation & Amortization	17.21	13.96	6.55	2.85	1.86	1.22
Stock-Based Compensation	119.39	130.26	116.01	82.47	51.97	26.18
Other Adjustments	-77.07	-85.28	-8.11	1.27	0.81	1.38
Change in Receivables	34.3	-26.23	-2.6	-30.22	-27.02	-9.24
Changes in Inventories	-48.82	-65.18	-46.23	-22	5.35	-8.75
Changes in Accounts Payable	-22.26	-3.75	0.6	9.3	14.36	4.78
Changes in Accrued Expenses	1.21	6.12	12.87	6.9	11.94	7.06
Changes in Other Operating Activities	-1.78	1.65	-2.34	-4.76	-2.82	-0.7
Operating Cash Flow	157.07	116.98	130.25	24.65	11.57	-20.12
Operating Cash Flow Growth	33.74%	-10.19%	428.32%	113.09%	-	-
Capital Expenditures	-39.98	-38.5	-39.12	-23.63	-9.1	-4.67
Purchases of Investments	-211.33	-250.44	-418.6	-281.44	-10.5	-9.99
Proceeds from Sale of Investments	230.16	310.38	344.61	10.25	-	43.8
Investing Cash Flow	-31.26	21.45	-113.12	-294.82	-19.6	29.14
Long-Term Debt Repaid	-	-	-	-	-24.5	-
Net Long-Term Debt Issued (Repaid)	-	-	-	-	-24.5	-
Issuance of Common Stock	5.45	14.61	27.77	31.11	259.62	14.95
Repurchase of Common Stock	-100.01	-175.02	-75	-	-	-
Net Common Stock Issued (Repurchased)	-94.56	-160.41	-47.23	31.11	259.62	14.95
Other Financing Activities	-10.4	-23.04	-5.17	-17.16	-0.04	-
Financing Cash Flow	-104.96	-183.45	-52.39	13.95	235.08	14.95
Foreign Exchange Rate Adjustments	-0.02	-0.31	-0.12	0.16	0.08	-0.02
Net Cash Flow	20.83	-45.34	-35.39	-256.06	227.13	23.95
Free Cash Flow	117.09	78.48	91.12	1.02	2.47	-24.79
Free Cash Flow Growth	37.74%	-13.88%	8798.73%	-58.59%	-	-
FCF Margin	13.03%	8.61%	11.35%	0.16%	0.61%	-10.62%
Free Cash Flow Per Share	4.02	2.64	2.98	0.03	0.09	-0.91
Levered Free Cash Flow	40.61	59.73	-14.17	-52.5	-47.79	-43.1
Unlevered Free Cash Flow	10.91	27.1	-34.65	-74.14	-26.66	-40.98

SEC Filings: 10-K · 10-Q